Please note that the English version of this text has been prepared with the assistance of AI, and in some instances, it may not have been subsequently reviewed or edited by the authors.
On 21 May, Scott Dax, PhD in Chemistry (USA), presented his biotechnology commercialisation experience at the Organic Synthesis Institute (OSI). He is an expert in the discovery and development of new drugs with more than 25 years of experience in drug development and commercialisation of ideas. Read more.
Photo by Inese Kalniņa
